Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,275 | 57,288 | 47,186 | 45,315 | 38,329 |
| Receivables | 93,142 | 97,070 | 94,729 | 95,942 | 83,698 |
| Other current assets | 351,768 | 395,967 | 74,895 | 525,705 | 74,637 |
| TOTAL | $499,579 | $557,108 | $221,232 | $668,487 | $199,264 |
| Non-Current Assets | |||||
| PPE Net | 1,889,266 | 1,882,452 | 2,177,336 | 1,816,794 | 2,300,574 |
| Investments And Advances | 472,790 | 460,235 | 465,041 | 473,792 | 444,741 |
| Intangibles | 20,319 | 20,722 | 21,125 | 21,527 | 21,978 |
| Other Non-Current Assets | 68,780 | 64,373 | 33,181 | 32,017 | 32,608 |
| TOTAL | $2,451,155 | $2,427,782 | $2,696,683 | $2,344,130 | $2,799,901 |
| Total Assets | $2,950,734 | $2,984,890 | $2,917,915 | $3,012,617 | $2,999,165 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 309,500 | 313,064 | 318,664 | 311,381 | 194,563 |
| Accounts payable and accrued liabilities | 64,870 | 84,035 | 64,252 | 81,510 | 265,209 |
| Accrued Expenses | 25,981 | 21,509 | 19,869 | 25,069 | 18,882 |
| TOTAL | $406,706 | $425,056 | $408,001 | $425,533 | $486,999 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,819,649 | 1,825,858 | 1,764,695 | 1,847,633 | 1,777,420 |
| Deferred Revenues | 6,355 | 6,448 | 5,216 | 7,573 | 8,345 |
| Other Non-Current Liabilities | 5,333 | 1,784 | 1,961 | 0 | 0 |
| TOTAL | $1,858,036 | $1,867,648 | $1,805,605 | $1,885,952 | $1,815,697 |
| Total Liabilities | $2,264,742 | $2,292,704 | $2,213,606 | $2,311,485 | $2,302,696 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,426 | 17,420 | 17,935 | 18,712 | 19,306 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 487,653 | 494,607 | 487,479 | 471,112 | 453,912 |
| Other shareholders' equity | 97,020 | 97,276 | 97,271 | 97,352 | 97,486 |
| TOTAL | $685,992 | $692,186 | $704,309 | $701,132 | $696,469 |
| Total Liabilities And Equity | $2,950,734 | $2,984,890 | $2,917,915 | $3,012,617 | $2,999,165 |